Up about 12%, Tempus AI (NASDAQ:TEM) has been explosive. Helping, its volume just spiked to 18.6 million shares, as compared ...

Eric Lefkofsky, founder and CEO of Tempest AI, explains the impact of acquiring Ambry, a genetic testing company, which ...

Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care ...

In a regulatory filing on Friday, Tempus AI (TEM) disclosed that Chairman and CEO Eric Lefkofsky sold a series of shares ...

Just 10 days after Pelosi’s AI stock acquisition, the chief executive officer (CEO) of the company dumped $62 million worth ...

Eric Lefkofsky, CEO and Chairman of Tempus AI , Inc. (NASDAQ:TEM), recently sold a significant portion of his holdings, ...

Shares of Tempus AI (TEM) are down 92c, or 2%, to $49.53 in Thursday morning trading after it was disclosed in a regulatory filing last night ...

Now, as AI becomes increasingly integrated into healthcare, tools like Olivia will be essential in helping patients understand and navigate their care," said Eric Lefkofsky, founder and CEO of Tempus.

Tempus AI’s strategic moves and groundbreaking technological applications mark it as a key player in the future of precision ...

Tempus AI stock had its best day on record on Tuesday after the medical tech company launched an AI-powered health concierge and former House Speaker Nancy Pelosi revealed she's bet on the stock.

Now, as AI becomes increasingly integrated into healthcare, tools like Olivia will be essential in helping patients understand and navigate their care,” said Eric Lefkofsky, Founder and CEO of ...